weight loss drug news today glp-1 A new study is raising concerns about drugs and eating disorders. Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least Amazon's New GLP‑1 Service Promises
Description
doi: 10.2337/dc19-S004
A post-hoc sensitivity analysis excluding ITCA 650 validated the robustness of the pooled hazard ratio (Supplementary Figure D6)
The drug will be marketed as the Wegovy Pill
(2003) Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide
(Or) overdosing without dose control, patients may inject too much, increasing the risk of side effects like nausea, vomiting, diarrhea, or constipation. Hans J
